Maravai LifeSciences Holdings, Inc. (MRVI)
Automate Your Wheel Strategy on MRVI
With Tiblio's Option Bot, you can configure your own wheel strategy including MRVI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MRVI
- Rev/Share 1.6863
- Book/Share 3.6972
- PB 1.0353
- Debt/Equity 0.1236
- CurrentRatio 5.9578
- ROIC -0.2925
- MktCap 312425750.0
- FreeCF/Share -0.1617
- PFCF -13.4748
- PE -1.9128
- Debt/Assets 0.0387
- DivYield 0
- ROE -0.4623
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | MRVI | Robert W. Baird | Outperform | Neutral | $9 | $3 | Feb. 26, 2025 |
| Initiation | MRVI | Guggenheim | -- | Neutral | -- | -- | Dec. 19, 2024 |
| Downgrade | MRVI | Goldman | Neutral | Sell | -- | $4.25 | Dec. 5, 2024 |
| Initiation | MRVI | Wells Fargo | -- | Overweight | -- | $10 | Aug. 28, 2024 |
News
Shareholders that lost money on Maravai LifeSciences Holdings, Inc. (MRVI) should contact Levi & Korsinsky about pending Class Action - MRVI
Published: April 16, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=143400&wire=1 or contact Joseph E. Levi, Esq.
Read More
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences Lawsuit - MRVI
Published: April 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=143134&wire=1 or contact Joseph E. Levi, Esq.
Read More
MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI
Published: April 15, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , April 15, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) for violations of the federal securities laws. Shareholders who purchased the Company's securities between August 7, 2024 and February 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 5, 2025.
Read More
Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI
Published: April 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142986&wire=1 or contact Joseph E. Levi, Esq.
Read More
Atkore Inc. (ATKR) Class Period Expanded in Second Securities Class Action Suit Over Recording of Potentially Improper Revenues – Hagens Berman
Published: April 14, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, April 14, 2025 (GLOBE NEWSWIRE) -- A second class action lawsuit has been filed against Atkore Inc. (NYSE: ATKR), a prominent manufacturer of electrical products, which include metal electrical conduit and fittings, plastic pipe conduit and fittings, electrical cable and flexible conduit, and international cable management systems. The second suit, captioned Coles, II v.
Read More
Maravai LifeSciences Holdings, Inc. Class Action: Levi & Korsinsky Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
Published: April 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142972&wire=1 or contact Joseph E. Levi, Esq.
Read More
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI) - May 5, 2025 Deadline to Join - Contact Levi & Korsinsky
Published: April 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142926&wire=1 or contact Joseph E. Levi, Esq.
Read More
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: April 14, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , April 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 7, 2024 and February 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 5, 2025.
Read More
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences Lawsuit - MRVI
Published: April 11, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142562&wire=1 or contact Joseph E. Levi, Esq.
Read More
Ibotta, Inc. Announcement: If You Have Suffered Losses in Ibotta, Inc. (NYSE: IBTA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Published: April 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA) resulting from allegations that Ibotta may have issued materially misleading business information to the investing public.
Read More
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders
Published: April 11, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142525&wire=1 or contact Joseph E. Levi, Esq.
Read More
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
Published: April 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline.
Read More
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
Published: April 10, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , April 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2025 lead plaintiff deadline. So what: If you purchased Maravai securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
MRVI LAWSUIT ALERT: Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Published: April 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142313&wire=1 or contact Joseph E. Levi, Esq.
Read More
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: April 10, 2025 by: PRNewsWire
Sentiment: Neutral
BENSALEM, Pa. , April 10, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Read More
Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI
Published: April 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142280&wire=1 or contact Joseph E. Levi, Esq.
Read More
Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRVI
Published: April 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142262&wire=1 or contact Joseph E. Levi, Esq.
Read More
Maravai LifeSciences Holdings, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit
Published: April 10, 2025 by: PRNewsWire
Sentiment: Neutral
RADNOR, Pa. , April 10, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai") (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the "Class Period").
Read More
ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI
Published: April 09, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 9, 2025 / WHY: New York, N.Y., April 9, 2025.
Read More
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences Holdings, Inc. Lawsuit - MRVI
Published: April 09, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 9, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142062&wire=1 or contact Joseph E. Levi, Esq.
Read More
Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI
Published: April 09, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 9, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142049&wire=1 or contact Joseph E. Levi, Esq.
Read More
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders
Published: April 09, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 9, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=142036&wire=1 or contact Joseph E. Levi, Esq.
Read More
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Published: April 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
Published: April 09, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ:MRVI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
MRVI LAWSUIT ALERT: Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Published: April 08, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=141778&wire=1 or contact Joseph E. Levi, Esq.
Read More
Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending - Hagens Berman
Published: April 08, 2025 by: Accesswire
Sentiment: Neutral
SAN FRANCISCO, CA / ACCESS Newswire / April 8, 2025 / On Mar. 19, 2025, the price of Maravai LifeSciences (NASDAQ:MRVI) shares fell almost 6% after the company warned investors against relying on previously filed financial statements. Thismove lower follows a 21% drop on Feb. 25, 2025 after the company postponed its Q4 and FY 2024 earnings release and investor conference call.
Read More
Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI
Published: April 08, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=141766&wire=1 or contact Joseph E. Levi, Esq.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
Published: April 08, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , April 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
Lost Money on Maravai LifeSciences Holdings, Inc.(MRVI)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Published: April 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=141538&wire=1 or contact Joseph E. Levi, Esq.
Read More
ROSEN, A LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRVI
Published: April 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 7, 2025 / WHY: New York, N.Y., April 7, 2025.
Read More
About Maravai LifeSciences Holdings, Inc. (MRVI)
- IPO Date 2020-11-20
- Website https://www.maravai.com
- Industry Biotechnology
- CEO Mr. William E. Martin III
- Employees 570